Option Care Health’s (OPCH) Outperform Rating Reaffirmed at Barrington Research

Barrington Research reaffirmed their outperform rating on shares of Option Care Health (NASDAQ:OPCH) in a research note issued to investors on Thursday, Benzinga reports. They currently have a $38.00 price objective on the stock.

Separately, JMP Securities started coverage on shares of Option Care Health in a research report on Tuesday, July 16th. They set an outperform rating and a $36.00 price objective for the company.

Option Care Health Price Performance

Shares of OPCH opened at $31.00 on Thursday. The company has a market cap of $5.39 billion, a price-to-earnings ratio of 20.39, a PEG ratio of 1.51 and a beta of 1.24. Option Care Health has a 1-year low of $26.11 and a 1-year high of $35.74. The company’s fifty day simple moving average is $28.89 and its 200 day simple moving average is $30.75. The company has a current ratio of 1.77, a quick ratio of 1.39 and a debt-to-equity ratio of 0.74.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings data on Tuesday, April 23rd. The company reported $0.26 EPS for the quarter, topping analysts’ consensus estimates of $0.22 by $0.04. Option Care Health had a net margin of 6.15% and a return on equity of 18.92%. The firm had revenue of $1.15 billion during the quarter, compared to analysts’ expectations of $1.10 billion. During the same period in the previous year, the business posted $0.21 earnings per share. The company’s revenue for the quarter was up 12.8% compared to the same quarter last year. On average, research analysts forecast that Option Care Health will post 1.19 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Option Care Health

A number of institutional investors have recently modified their holdings of OPCH. Bank of New York Mellon Corp raised its stake in Option Care Health by 3.4% in the second quarter. Bank of New York Mellon Corp now owns 1,642,877 shares of the company’s stock valued at $45,508,000 after purchasing an additional 54,202 shares in the last quarter. Nicholas Company Inc. raised its stake in Option Care Health by 7.0% in the second quarter. Nicholas Company Inc. now owns 234,000 shares of the company’s stock valued at $6,482,000 after purchasing an additional 15,320 shares in the last quarter. MeadowBrook Investment Advisors LLC raised its stake in Option Care Health by 36.1% in the second quarter. MeadowBrook Investment Advisors LLC now owns 6,610 shares of the company’s stock valued at $183,000 after purchasing an additional 1,755 shares in the last quarter. Nisa Investment Advisors LLC raised its stake in Option Care Health by 5.4% in the second quarter. Nisa Investment Advisors LLC now owns 13,581 shares of the company’s stock valued at $376,000 after purchasing an additional 690 shares in the last quarter. Finally, Lifestyle Asset Management Inc. raised its stake in Option Care Health by 32.0% during the second quarter. Lifestyle Asset Management Inc. now owns 8,292 shares of the company’s stock worth $230,000 after acquiring an additional 2,009 shares in the last quarter. Institutional investors own 98.05% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.